𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma

✍ Scribed by Barbro Linderholm; Birgitta Lindh; Björn Tavelin; Kjell Grankvist; Roger Henriksson

Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
169 KB
Volume
89
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

The angiogenic factor vascular endothelial growth factor (VEGF) predicts outcome in primary breast carcinoma. Alteration of the p53 gene causes down-regulation of the expression of thrombospondin-1, a natural inhibitor of angiogenesis. This study was conducted to investigate the association between mutant p53 protein and VEGF expression, and the prognostic value of these factors. VEGF 165 and p53 protein were measured in tumour cytosols by enzyme immunoassays. Recurrence-free survival (RFS) and overall survival (OS) were estimated in 833 consecutive patients, 485 node-negative (NNBC) and 348 node-positive (NPBC) with primary invasive breast cancer. A significant association was found between mutant p53 protein and VEGF expression. Univariate analysis showed both p53 and VEGF to be significant predictors of survival. Similar correlation was seen when p53 was combined with VEGF. Univariate analysis of NNBC showed significant prognostic value of p53 for OS, also when combined with VEGF expression; for NPBC, significant reductions in RFS and OS were seen for p53-positive patients, and these findings were enhanced when combined with VEGF, also in the sub-group receiving adjuvant endocrine treatment. Multivariate analysis showed both p53 and VEGF as independent predictors of OS in all groups. When the 2 factors were combined, an increased relative risk of 2.7 was seen for OS in the group with both p53 positivity and high VEGF content, as compared with 1.7 in the group with one risk factor. The results suggest an association between loss of wt-p53 and increased VEGF expression, indicating that angiogenic activity may depend, at least partly, on altered p53-protein function. Combination of these 2 biological markers appears to give additional predictive information of survival. A high-risk group of patients was associated with p53 positivity and higher VEGF content.

📜 SIMILAR VOLUMES

Vascular permeability factor (Vascular e
Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast
✍ Anthony J. Guidi; Stuart J. Schnitt; Lars Fischer; Kathi Tognazzi; Jay R. Harris 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB 👁 1 views

histologic features on hematoxylin and eosin stained sections, and microvessel density and distribution using sections immunostained for factor VIII-related anti-1 Departments of Pathology, Beth Israel Deagen. In addition, in situ hybridization was performed on formalin fixed, paraffin coness Medica

Vascular endothelial growth factor expre
Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma : Association with angiogenesis and tumor progression
✍ Kimitoshi Inoue; Yuichi Ozeki; Toshiyuki Suganuma; Yoshiaki Sugiura; Susumu Tana 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 2 views

## Background: Angiogenesis is essential for solid tumor growth and metastasis. vascular endothelial growth factor (vegf), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator in vivo. conversely, there have been few studies of the

Combined analysis of p53 and vascular en
Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis
✍ Soon-Myoung Kang; Kiyoshi Maeda; Naoyoshi Onoda; Yong-Suk Chung; Bunzo Nakata; Y 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 326 KB 👁 1 views

Recent studies have demonstrated that the p53 tumor suppressor gene plays an important role in controlling tumor angiogenesis. We examined the expression of p53 and vascular endothelial growth factor (VEGF), a well-characterized angiogenic inducer, together with microvessel density to investigate th

Vascular endothelial growth factor expre
Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma
✍ Kiyoshi Maeda; Soon-Myoung Kang; Naoyoshi Onoda; Masafumi Ogawa; Yasuyuki Kato; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 2 views

Recently many studies have demonstrated that the degree of tumor angiogenesis is related to the aggressiveness of the tumor and clinical outcome. Vascular endothelial growth factor (VEGF) is a well characterized inducer of angiogenesis. In this study, the authors investigated the prognostic signifi

Expression of vascular endothelial growt
Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival
✍ Decaussin, Myriam; Sartelet, Herv�; Robert, Catherine; Moro, Denis; Claraz, Chri 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

The formation of new vessels (angiogenesis) is essential for primary tumour growth and metastasis and is induced by several angiogenic factors, including vascular endothelial growth factor (VEGF). The microvascular density (MVD) in tumours was assessed and the expression of VEGF and its receptors VE